IFN Beta CTP

Related by string. * IFNs : peg IFN . pegylated interferon peg IFN . IFN β . IFN ß . IFN α . IFN γ . IFN alpha . NYSE IFN / BETA . betas . Betas . beta. . BETAS . beta : Pi Beta Phi . Beta Theta Pi . Beta Sigma Phi . Zeta Phi Beta Sorority . graduated Phi Beta . beta blocker . site VERY BETA . interferon beta 1a / CtP . CTPs . CTPS . ctp : Agfa CtP . FSH CTP . hGH CTP . Caxton CTP . SNIA CTP . hGH CTP Phase . CTP platesetter * *

Related by context. All words. (Click for frequent words.) 69 Modigene 68 MAXY G# 67 PDE4 inhibitor 67 hGH CTP 67 recombinant Factor 66 visit biotech.com 66 PROLOR 65 somatostatin analogue 64 PNP inhibitor 64 synthetic retinoid 64 forodesine 64 TKM ApoB 64 agonist LABA 63 Factor VIIa 63 Interferon alpha 63 targeted radiotherapeutic 63 long acting muscarinic 63 Fc fusion protein 63 Xanafide 63 Allovectin 7 R 63 OvaRex R 63 pegylated 63 volociximab 63 novel histone deacetylase 62 Octreolin 62 Bezielle 62 PHX# 62 RhuDex ® 62 PEGylated interferon 62 rhMBL 62 orally administered inhibitor 62 octreotide acetate 62 Phase IIb clinical trials 62 acetonide FA 62 Protexia ® 62 Granulocyte Colony Stimulating Factor 62 orally dosed 62 subcutaneous formulation 62 TELINTRA 62 JAK inhibitor 62 Factor IX 61 Panzem R 61 immunomodulator 61 proteasome inhibitor 61 successfully commercialize Iluvien 61 PDL# 61 HuCAL antibodies 61 ASONEP 61 Specifid 61 subcutaneously administered 61 visilizumab 61 Anticalins R 61 Maribavir 61 beta 1a 61 molecular imaging radiopharmaceutical 61 PLK1 SNALP 61 immunomodulatory therapy 61 rxRNA 61 valopicitabine NM# 61 Oncaspar 61 YONDELIS 60 Bellicum 60 ADP receptor antagonist 60 EVIZON TM 60 novel oral anticoagulant 60 XL# anticancer compounds 60 AQ4N 60 Onconase 60 PEG SN# 60 intranasal formulation 60 oral talactoferrin 60 PGL# 60 Phase #b/#a clinical 60 IX Fc fusion 60 MAGE A3 ASCI 60 GVAX ® 60 enzyme rHuPH# 60 drug ISA# 60 factor G CSF 60 TBC# 60 recombinant Factor VIII 60 HuMax TAC 60 Allovectin 7 60 Anavex #-# 60 Bioral 60 Panzem R NCD 60 polymerase inhibitor 60 oral proteasome inhibitor 60 acting muscarinic antagonist 60 mertansine 60 HepeX B 60 MEK inhibitor 60 synthetic peptide containing 60 liposomal formulation 60 squalamine 60 Alfacell proprietary ribonuclease 60 CINTREDEKIN BESUDOTOX 60 Omacetaxine 60 highly selective inhibitor 60 Civacir 60 PORxin TM 60 Hsp# Inhibitor 59 Relivar 59 histone deacetylase inhibitor 59 phase IIb clinical 59 anticancer agent 59 Pradefovir 59 Myrexis 59 StemEx 59 acyclovir Lauriad R 59 Plicera 59 Epothilones 59 octreotide 59 generation purine nucleoside 59 GlycoPEG GCSF 59 HCD# [002] 59 ENMD # 59 non nucleoside 59 Talabostat 59 tizanidine hydrochloride short 59 selective adenosine 59 peripherally acting 59 HGS# 59 EP #R 59 epothilone 59 Daclizumab 59 cangrelor 59 humanized anti 59 systemically administered 59 VEGF inhibitors 59 Mycophenolate mofetil 59 radiation sensitizer 59 Aurora kinase inhibitor 59 Fentanyl TAIFUN R 59 HCV RNA polymerase 59 #D#C# 59 intradermal injection 59 depsipeptide 59 Dalbavancin 59 Amrubicin 59 proprietary intranasal insulin 59 Anthim 59 KNS # 59 Selective Electrochemical Tumor Ablation 59 nab docetaxel 59 Belerofon 59 ATryn ® 59 recombinant follicle stimulating 59 immune modulating 59 Maxy G# 59 selective androgen receptor modulator 59 sirtuin modulators 59 Preclinical studies suggest 59 NTDDS 59 immunotherapeutic vaccine 59 Bendamustine 59 immune stimulatory 59 CEQ# 59 hypoxia activated prodrug 59 glucokinase activator 59 chimeric monoclonal antibody 59 renin inhibitor 59 sargramostim 59 dipeptidyl peptidase IV 59 Generx TM 59 recombinant biopharmaceutical 59 MorphoSys proprietary 59 vidofludimus 59 Mipomersen 59 Soliris TM eculizumab 58 cyclin dependent kinase inhibitor 58 somatostatin analog 58 novel emulsion formulation 58 tezampanel NGX# 58 Cethrin 58 N acetylgalactosamine 6 58 CCR5 antagonist 58 HQK 58 Nasulin ™ 58 siRNAs targeting 58 Lixivaptan 58 SomatoKine 58 HuMax CD4 58 aldehyde dehydrogenase ALDH2 deficiency 58 CCX# 58 Curaxin 58 receptor tyrosine kinase inhibitor 58 IAP inhibitor 58 PEGylated interferon beta 1a 58 orally bioavailable 58 nucleoside analog 58 tafamidis 58 novel VDA molecule 58 Syntonix 58 R sorafenib tablets 58 A5 Labs 58 histone deacetylase HDAC inhibitor 58 HSP# inhibitor 58 PrevOnco 58 Solazed 58 ospemifene 58 Silodosin 58 GRNVAC1 58 ONTAK 58 XTEN 58 rFIXFc 58 Orphan Drug designations 58 orally inhaled 58 TYZEKA 58 Nexavar ® 58 THR beta agonist 58 Tarceva TM 58 Alzhemed TM 58 AAG geldanamycin analog 58 rFSH 58 non nucleoside HCV 58 forodesine hydrochloride 58 octreotide implant 58 LHRH antagonist 58 TRX1 58 cathepsin K inhibitor 58 drug pipeline TAFA# 58 TRISENOX ® 58 XP# XP# 58 HepDirect prodrug 58 Orphan Drug designation 58 tranilast 58 novel immunomodulatory 58 AKT inhibitor 58 PD LID 58 Belinostat 58 Liprotamase 58 PrevOnco ™ 58 RhuDex R 58 Prodarsan ® 58 injectable atypical antipsychotic 58 SinuNase ™ 58 CIMZIA TM 58 paliperidone palmitate 58 targeted antifolate 58 ARIKACE ™ 58 Argatroban 58 PRT# 58 selective modulator 58 pomalidomide 58 small molecule activators 58 oncolytic virus therapies 58 potently inhibit 58 recombinant interferon 58 prostanoid 58 targeting CD# 58 Targeted Chemotherapy 58 ALN PCS 58 refractory chronic lymphocytic 58 ART# 58 sorafenib tablets 58 sorafenib Nexavar 58 AVP #D# 58 HIV integrase inhibitor 58 Vilazodone 58 Certolizumab 58 Bicifadine 58 MVA BN 58 telomerase inhibitor drug 58 Cloretazine ® 58 Syncria 58 Hyphanox 58 rhFVIIa 58 amrubicin 58 Cerashield ™ 58 Canvaxin TM 58 incyclinide 57 Eligen ® Technology 57 2 methoxyestradiol 57 TLR9 agonist 57 trivalent influenza vaccine 57 AVONEX ® 57 highly selective adenosine 57 hormone LHRH antagonist 57 oral prodrug 57 preclinical efficacy 57 selective serotonin 2C receptor 57 HCV protease inhibitor 57 EZN 57 Myocet 57 AN# novel 57 HCV polymerase inhibitor 57 HuLuc# 57 Interferon alfa 57 EVIZON TM squalamine lactate 57 LEP ETU 57 thrombolytic agent 57 Xeloda ® 57 sapacitabine CYC# 57 anticancer compound 57 oncolytic vaccine 57 NanoTab 57 dirucotide MBP# 57 phase IIa clinical 57 Prolor 57 ALN TTR 57 Spiegelmer ® 57 NK1 57 PARP inhibitor 57 docetaxel Taxotere R 57 entacapone 57 Aerosurf 57 small molecule chemotherapeutic 57 cutaneous T 57 RNA antagonist 57 humanised monoclonal antibody 57 Excellarate TM 57 CG# [003] 57 alpha antagonist 57 BAY #-# 57 vosaroxin 57 developing TB4 57 Pruvel 57 carcinoid syndrome 57 valtorcitabine 57 siRNA therapeutics 57 XL# XL# XL# XL# 57 Phase IIb trials 57 PDX pralatrexate 57 Clevudine 57 aurora kinase 57 LentiVector 57 InterfeRx 57 PEGylated 57 Unit Dose Budesonide 57 PEGylated anti 57 Glybera 57 GLP toxicology studies 57 ALN TTR# 57 PTH1 57 vascular disrupting agents 57 huC# DM4 57 AMPK activators 57 Cleviprex TM clevidipine 57 lintuzumab SGN 57 IL# PE#QQR 57 non nucleoside inhibitor 57 DOS# 57 xanthine oxidase inhibitor 57 Anidulafungin 57 IV Busulfex 57 vascular disrupting agent 57 MTP inhibitor 57 CORT # 57 DURIN TM 57 HCV protease inhibitors 57 novel peptides 57 polysaccharide polymer 57 TRO# 57 Protexia R 57 MAXY alpha 57 nucleoside reverse transcriptase inhibitor 57 Vidofludimus 57 immune modulators 57 splice variants 57 telaprevir VX 57 remission induction 57 delta opioid receptor 57 Zevalin R Ibritumomab 57 PTH analogue 57 KSP inhibitor 57 sitaxsentan 57 RTP #i 57 trastuzumab DM1 T DM1 57 Zerenex ™ 57 Plenaxis TM 57 PSMA ADC 57 histone deacetylase HDAC inhibitors 57 sodium glucose transporter 57 MEK inhibitors 57 AERx iDMS 57 rHuPH# 57 samalizumab 57 reformulates existing FDA 57 anti angiogenic agent 57 anti CD3 monoclonal 57 alfa interferon 57 Cloretazine 57 Apoptone 57 TKB# 57 personalized cellular immunotherapy 57 eligen 57 Perforomist ™ Inhalation Solution 57 antisense drug 57 daptomycin 57 small molecule tyrosine 57 Cintredekin Besudotox 57 BXT # 57 reslizumab 57 STEDESA 57 Zorbtive TM 57 histone deacetylase HDAC 57 eligen R technology 57 estrogen receptor antagonist 57 otelixizumab 57 hypereosinophilic syndrome 57 Laquinimod 57 Virulizin R 57 XL# XL# 57 peptide conjugated 57 Peginterferon alfa 2b 57 oral nucleoside analogue 57 metaglidasen 57 liposomal delivery 57 marketed pegylated interferons 57 humanized monoclonal antibody 57 FSH CTP 57 RenaZorb TM 57 miconazole Lauriad R 57 Onco TCS 57 therapeutic proteins 56 urocortin 2 56 ALGRX 56 DIFICID ™ 56 Emezine 56 GeneICE 56 DMAG 56 HaptoGuard 56 pathophysiological effects 56 rNAPc2 56 BCR ABL inhibitors 56 PSN# [001] 56 Biopump 56 Traficet EN 56 Dextofisopam 56 5 HT3 antagonist 56 therapeutic monoclonal antibodies 56 personalized immunotherapy 56 RAPAFLO 56 SNS# T 56 tiapamil 56 Voreloxin 56 somatostatin 56 Tß4 56 LNP formulations 56 EOquin 56 TRIOLEX 56 Vivaglobin 56 oral taxane 56 Anticalin R 56 Prednisporin 56 dirucotide 56 Surfaxin LS 56 class mGluR5 inhibitor 56 Cerashield 56 RECOTHROM R 56 fluoropyrimidine 56 Anticalin ® 56 methylnaltrexone 56 adecatumumab MT# 56 OvaRex MAb 56 fosbretabulin 56 novel anticancer 56 injectable depot 56 5 HT2A inverse 56 prokinetic agent 56 Adlea TM 56 CYT# potent vascular disrupting 56 intranasal insulin product 56 Cellegesic 56 Archexin 56 Aflibercept 56 Synavive 56 Shigamabs ® 56 tubulin inhibitor 56 synthetic siRNA 56 EndoTAG TM 56 ZOLINZA 56 sulindac 56 MAXY VII 56 TELCYTA 56 PEGylated Fab fragment 56 Cytolin R 56 isoform selective 56 R roscovitine 56 HBV vaccine 56 JAK2 Inhibitor 56 OHR/AVR# 56 SARMs 56 cytokine refractory 56 Targretin capsules 56 positive allosteric modulator 56 treat chronic sinusitis 56 nucleotide analog 56 synDNA TM 56 anti secretory 56 Soliris eculizumab 56 markets HP Acthar 56 INCB# [001] 56 RNAi therapeutic targeting 56 ATL/TV# 56 BioMarck 56 muscarinic receptor agonist 56 CIP TRAMADOL ER 56 Exelixis compounds 56 Orapred ODT 56 Chrysalin 56 ATL# [002] 56 TKM PLK1 56 IMiDs R 56 Phase Ib study 56 BLP# Liposome Vaccine 56 AGS PSCA 56 plasmid encoding 56 oral dihydropyrimidine dehydrogenase DPD 56 Nitec 56 talactoferrin 56 Elvitegravir 56 inhaled liposomal ciprofloxacin 56 Halozyme Ultrafast Insulin 56 Luteinizing Hormone Releasing Hormone 56 dacetuzumab 56 Hsp# inhibitors 56 Zysolin TM 56 selective inhibition 56 bendamustine 56 erlotinib Tarceva ® 56 ImmunGene 56 preclinically 56 TREANDA 56 GelSite polymer 56 partial agonist 56 Adnectin 56 SAR# [004] 56 topical antifungal 56 oral transmucosal 56 investigational oral 56 cetuximab Erbitux R 56 IFN alpha XL 56 Squalamine 56 Panzem ® 56 therapeutic monoclonal antibody 56 Pimavanserin 56 Teriflunomide 56 GLPG# 56 oral picoplatin 56 XmAb 56 Azixa 56 selective inhibitor 56 Fibrillex TM 56 glucagon receptor 56 BioGeneriX 56 VivaGel TM 56 androgen receptor antagonist 56 maturation inhibitor 56 ADVEXIN p# therapy 56 Saxagliptin 56 Lamictal ODT 56 Transfection Reagent 56 poly ADP ribose polymerase 56 A2A receptor 56 AdhTAP 56 immunomodulatory 56 insulin sensitizers 56 NPC 1C 56 PEG IFN 56 avian transgenic 56 Lubiprostone 56 NeuroSolutions 56 vaccine GRNVAC1 56 thrombin inhibitor 56 dihydrochloride 56 HDL Selective Delipidation 56 Asentar 56 Dasatinib 56 lumiliximab 56 CDK inhibitor 56 casopitant 56 Insegia 56 ZYBRESTAT 56 Meritage Pharma 56 Urocidin TM 56 Fresenius Biotech 56 HepaGam B 56 DP VPA 56 cyclophilin inhibitor 56 Interferon beta 56 PentaStaph 56 renin inhibitors 56 Cimzia TM 56 Iluvien ® 56 Hedgehog pathway inhibitor 56 GLASSIA 56 Cloretazine R VNP#M 56 TG# [003] 56 Nascobal 56 kidney urologic 56 albiglutide 56 HspE7 56 epothilones 56 Oral Spray 56 MYLOTARG 56 mRNA antagonists 56 DiaPep# 56 JAK3 56 Romidepsin 56 epigenetic therapies 56 AEG# 56 Frova ® 56 MoxDuo 56 mitogen activated ERK kinase 56 NV1FGF 56 transmucosal film 56 Lovaza TM 55 PRAECIS 55 Ozarelix 55 Urocidin 55 Alferon N 55 mesylate 55 eltrombopag 55 direct thrombin inhibitor 55 Pegloticase 55 TELINTRA R 55 pradefovir 55 AGTC 55 lexidronam injection 55 histamine dihydrochloride 55 oral ridaforolimus 55 interferon alfa 2b 55 AMEVIVE 55 Fc fusion protein rFVIIIFc 55 MT# MEDI 55 UPLYSO 55 CD# CEA 55 LymphoStat B TM 55 bortezomib Velcade 55 LOMUCIN TM 55 prostone 55 NurOwn 55 VIBEX MTX 55 anticoagulant reversing agent 55 ProMune 55 selective A2A adenosine receptor 55 JAK2 inhibitor 55 Tezampanel 55 Prestara 55 Apo AIMilano 55 RONDEL ™ 55 antiangiogenic agent 55 transfection reagents 55 potent topoisomerase II 55 Zenvia ™ 55 TASKi3 55 Arimoclomol 55 nonclinical studies 55 Kahalalide F 55 selective androgen receptor modulators 55 GATTEX ® 55 selective antagonist 55 Fx #A 55 personalized dendritic 55 Aurora kinase 55 humanized antibodies 55 PI3K/Akt pathway inhibitor 55 Cathepsin S 55 Reverset 55 Uricase PEG 55 fentanyl formulation 55 anti fibrotic 55 inhaled formulation 55 nucleoside analogue 55 Debio 55 JUVISTA R Human 55 Ampligen r 55 P#X# antagonist 55 elotuzumab 55 Troxatyl 55 injectable formulation 55 AeroLEF R 55 pharmacodynamic properties 55 oral antiviral 55 regorafenib 55 Oasmia 55 CD# monoclonal antibody 55 elvucitabine 55 investigational antiplatelet agent 55 herpetic keratitis 55 granisetron 55 Src inhibitors 55 GSK# [001] 55 polymerase inhibitors 55 TNF Tumor Necrosis Factor 55 NexACT 55 potent antiproliferative 55 MNTX 55 JAK1 55 nitric oxide donating 55 PREOS 55 SGLT 55 uricase 55 protein tyrosine phosphatase 1B 55 Hsp# inhibitor 55 EndoTAG TM -1 55 JAK inhibitors 55 favorable pharmacokinetic profile 55 SERMs 55 recombinant FVIII 55 Memryte 55 unoprostone isopropyl 55 CB2 selective 55 Telintra 55 Dacogen decitabine 55 Octreotide 55 CDP# 55 Symadex 55 NXL# 55 YONDELIS R 55 thymalfasin 55 NS5A 55 CCR5 inhibitor 55 Phase IIa trials 55 Phase IIa clinical trials 55 Phase 2a trial 55 fostamatinib 55 SRT# [003] 55 busulfan 55 humanized monoclonal 55 DepoVax TM 55 R#/MEM # 55 endothelin receptor antagonists 55 oral formulations 55 MOVIPREP R 55 ProLindac TM 55 RECOTHROM ® 55 Sangamo ZFP technology 55 humanized antibody 55 Pyridorin TM 55 SARcode 55 GelSite R polymer 55 epoetin alpha 55 cancer immunotherapies 55 tolevamer 55 lintuzumab 55 Prednisporin TM 55 oxymorphone ER 55 Dyloject TM 55 Aptivus ® 55 darinaparsin ZIO 55 alvespimycin 55 Vascular Wrap TM 55 selective immunoproteasome inhibitor 55 Nuvion 55 AERx ® 55 cannabinor 55 EGRIFTA TM 55 anti CD# antibody 55 blood clot dissolver 55 Loxapine 55 developing Bicifadine serotonin 55 Marqibo TM 55 brostallicin 55 sodium glucose cotransporter 55 IgG1 monoclonal antibody 55 Nebido 55 SCIB1 55 IV APAP 55 iSONEP 55 candidate deforolimus 55 antibody MAb 55 CCR2 55 Cobalamin 55 Sandostatin LAR 55 Atrasentan 55 Atrigel 55 Ceragenin ™ 55 interferon gamma 1b 55 Fleximer 55 Albugon 55 factor VIIa 55 Aviptadil 55 diarrhea predominant irritable 55 SonoLysis 55 Personalized Immunotherapy 55 HGS ETR2 55 OROS ® 55 Acetylon 55 hydrochloride capsules 55 coagulation factor VIIa 55 Zuplenz 55 untreated multiple myeloma 55 Fludara ® 55 Cetrorelix pamoate 55 quinolone 55 PXD# 55 Mesafem 55 novel therapeutic antibodies 55 inhaled formulations 55 pharmacological chaperone 55 Amplimexon 55 EVIZON ™ 55 VaxImmune 55 Irinotecan 55 XYOTAX TM 55 PI3K inhibitor 55 chemical entities NCEs 55 UVIDEM 55 relapsed MM 55 OMNARIS HFA 55 Intellikine 55 Combidex 55 selectively inhibits 55 luteinizing hormone releasing 55 lipoprotein lipase deficiency LPLD 55 anti emetic therapy 55 R tizanidine hydrochloride 55 Moxifloxacin 55 OXi# 55 sevelamer hydrochloride 55 Annamycin 55 Vaxfectin TM adjuvant 55 Sorafenib Nexavar 55 anticancer therapeutics 55 selective orally bioavailable 55 oral methylnaltrexone 55 PANVAC VF 55 alkylating agent 55 REG1 55 oral anticoagulant 55 intravesical instillation 55 alagebrium 55 CCX# B 55 systemic immunosuppressive drugs 55 aerosolized AAT 55 OncoGel 55 Allovectin 7 r 55 Beta catenin pathway 55 Prosaptide 55 anti emetic 55 #ME# 55 ISTODAX 55 ceftazidime 55 antitumoral 55 Zoraxel TM 54 ATL# [001] 54 ELACYT 54 ara C 54 VAPRISOL 54 interferon IFN 54 Intraject 54 highly purified pasteurized 54 Trofex 54 pan HDAC inhibitor 54 Enzyme Replacement Therapy 54 RNA antagonists 54 XmAb# 54 Triapine R 54 IAP inhibitors 54 rusalatide acetate 54 Vernakalant 54 antifolate 54 Rasagiline 54 JVRS 54 Kosan dependence 54 NOX A# 54 Genz # 54 Viprinex TM 54 Bortezomib 54 using VIAdel TM 54 Vaxfectin 54 Zanaflex Capsules TM 54 factor Xa inhibitor 54 SYGNIS 54 BiTE 54 romazarit 54 anticancer agents 54 peptide antigens 54 CCR9 antagonist 54 stated Michelle Berrey 54 KSP inhibitors 54 injectable formulations 54 CIMYM 54 Rescula 54 NMDA antagonist 54 investigational drug 54 Forodesine HCl 54 ACZ# 54 NanoStat 54 CTAP# Capsules 54 BAL# [002] 54 erythropoietic 54 candidate AQ4N 54 Virium 54 lixivaptan 54 Solzira 54 buccal spray 54 OTCBB HXBM developer 54 celgosivir 54 dexpramipexole 54 balsalazide tablet 54 NGX# 54 Adenoscan 54 Phenoptin 54 Ostabolin C TM 54 NP2 Enkephalin 54 Intarcia 54 Sebivo 54 Zavesca r 54 axitinib 54 RELISTOR ® 54 ELND# 54 Preotact 54 bardoxolone 54 Urokinase 54 TH# [003] 54 lesinurad 54 TRISENOX 54 injectable antipsychotic 54 thrombin inhibiting aptamer 54 siRNA therapeutic 54 Phase 2b clinical trials 54 nanopharmaceutical 54 ocular formulation 54 dasatinib Sprycel ® 54 CYC# 54 Poly ICR 54 preclinical pharmacokinetic 54 skeletal muscle activator 54 muscarinic antagonist 54 GRN# 54 punctal plug delivery 54 kinase inhibitor 54 oral Hsp# inhibitor 54 Tyrima 54 peginesatide 54 Curacyte 54 XmAb ® 54 RSD# oral 54 KRN# 54 Zalbin 54 Preclinical studies 54 vismodegib 54 trastuzumab Herceptin R 54 RenaZorb 54 Phase Ib clinical trials 54 thrombopoietin 54 Tesmilifene 54 Vaxfectin R adjuvant 54 PSN# [002] 54 Panzem 54 ALTU 54 immunomodulating 54 Ocrelizumab 54 2A receptor agonist 54 pafuramidine 54 tivozanib AV 54 Curaxins 54 molecular chaperone regulation 54 Iloperidone 54 ErbB3 54 NeuVax 54 PORxin TM platforms 54 DB# [003] 54 Xyfid TM 54 GW# [003] 54 hESC derived 54 MGd 54 ALN HPN 54 angiogenesis inhibitor 54 EndoTAG 54 inhibitor RG# 54 ENTB 54 Glufosfamide 54 ALTROPANE R 54 INxin TM 54 virosome 54 ProAlgaZyme 54 PRECISE trial 54 terlipressin 54 proprietary MSCRAMM ® 54 AzaSite Plus 54 LentiVector technology 54 Vandetanib 54 Troxatyl TM 54 Sopherion 54 Perifosine 54 nilotinib Tasigna ® 54 ZFP TFs 54 2 inhibitor CYT# 54 prodrugs 54 Guanilib 54 multitargeted 54 seliciclib CYC# 54 CVac 54 therapeutic mAbs 54 somatostatin analogues 54 Plasmin 54 oral salmon calcitonin 54 CCR1 54 CD3 monoclonal antibody 54 Lantibio 54 pharmacologically active isomer 54 triphendiol 54 GelSite ® 54 Nabi HB Intravenous

Back to home page